Neutrophil extracellular traps are increased in cancer patients but does not associate with venous thrombosis

Rahmi Oklu, Rahul A. Sheth, Keith H.K. Wong, Amin H. Jahromi, Hassan Albadawi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: A single center, prospective tissue-based study was conducted to investigate an association between neutrophil extracellular traps (NETs) and venous thromboembolic disease in patients with malignancy. Methods: Plasma was collected from 65 patients in which 27 were cancer patients and 38 were age-matched non-cancer patients. Plasma NETs, circulating free DNA (cfDNA), DNase-1, endonuclease-G, endonuclease activity and thrombin-antithrombin III (TAT) complex levels was quantified. Laboratory values were also compared. Additionally, NETs detection and quantification was performed with fluorescent immunohistochemistry (IHC) in tissue-banked tumor sections and fresh human venous thrombus derived from cancer patients. Results: Plasma samples from cancer patients contained higher levels of nucleosomes (P=0.0009) and cfDNA (P=0.0008) compared to the non-cancer group. Western blot analysis revealed significantly lower DNase-1 protein levels (P=0.016) that paralleled lower nuclease activity (P=0.03) in plasma samples from cancer patients compared to non-cancer patients. Thrombus tissue from cancer patients and tumor tissue from liver and lung cancer also showed marked levels of NETs. However, increased levels of NETs in cancer patients did not correlate with TAT complex activation or prevalence of venous thrombosis in cancer patients. Conclusions: Further studies are warranted to determine the role of NETs as a procoagulant in human thrombosis.

Original languageEnglish (US)
Pages (from-to)S140-S149
JournalCardiovascular Diagnosis and Therapy
Volume7
DOIs
StatePublished - Dec 1 2017

Fingerprint

Venous Thrombosis
Neoplasms
Thrombosis
Deoxyribonucleases
Extracellular Traps
Nucleosomes
Endonucleases
DNA
Liver Neoplasms
Lung Neoplasms
Western Blotting
Immunohistochemistry

Keywords

  • NETs
  • Neutrophil extracellular traps
  • Nuclease
  • Thrombosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Neutrophil extracellular traps are increased in cancer patients but does not associate with venous thrombosis. / Oklu, Rahmi; Sheth, Rahul A.; Wong, Keith H.K.; Jahromi, Amin H.; Albadawi, Hassan.

In: Cardiovascular Diagnosis and Therapy, Vol. 7, 01.12.2017, p. S140-S149.

Research output: Contribution to journalArticle

@article{b365782a6e21446ea434eb3c6e8cc5dd,
title = "Neutrophil extracellular traps are increased in cancer patients but does not associate with venous thrombosis",
abstract = "Background: A single center, prospective tissue-based study was conducted to investigate an association between neutrophil extracellular traps (NETs) and venous thromboembolic disease in patients with malignancy. Methods: Plasma was collected from 65 patients in which 27 were cancer patients and 38 were age-matched non-cancer patients. Plasma NETs, circulating free DNA (cfDNA), DNase-1, endonuclease-G, endonuclease activity and thrombin-antithrombin III (TAT) complex levels was quantified. Laboratory values were also compared. Additionally, NETs detection and quantification was performed with fluorescent immunohistochemistry (IHC) in tissue-banked tumor sections and fresh human venous thrombus derived from cancer patients. Results: Plasma samples from cancer patients contained higher levels of nucleosomes (P=0.0009) and cfDNA (P=0.0008) compared to the non-cancer group. Western blot analysis revealed significantly lower DNase-1 protein levels (P=0.016) that paralleled lower nuclease activity (P=0.03) in plasma samples from cancer patients compared to non-cancer patients. Thrombus tissue from cancer patients and tumor tissue from liver and lung cancer also showed marked levels of NETs. However, increased levels of NETs in cancer patients did not correlate with TAT complex activation or prevalence of venous thrombosis in cancer patients. Conclusions: Further studies are warranted to determine the role of NETs as a procoagulant in human thrombosis.",
keywords = "NETs, Neutrophil extracellular traps, Nuclease, Thrombosis",
author = "Rahmi Oklu and Sheth, {Rahul A.} and Wong, {Keith H.K.} and Jahromi, {Amin H.} and Hassan Albadawi",
year = "2017",
month = "12",
day = "1",
doi = "10.21037/cdt.2017.08.01",
language = "English (US)",
volume = "7",
pages = "S140--S149",
journal = "Cardiovascular Diagnosis and Therapy",
issn = "2223-3652",
publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Neutrophil extracellular traps are increased in cancer patients but does not associate with venous thrombosis

AU - Oklu, Rahmi

AU - Sheth, Rahul A.

AU - Wong, Keith H.K.

AU - Jahromi, Amin H.

AU - Albadawi, Hassan

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Background: A single center, prospective tissue-based study was conducted to investigate an association between neutrophil extracellular traps (NETs) and venous thromboembolic disease in patients with malignancy. Methods: Plasma was collected from 65 patients in which 27 were cancer patients and 38 were age-matched non-cancer patients. Plasma NETs, circulating free DNA (cfDNA), DNase-1, endonuclease-G, endonuclease activity and thrombin-antithrombin III (TAT) complex levels was quantified. Laboratory values were also compared. Additionally, NETs detection and quantification was performed with fluorescent immunohistochemistry (IHC) in tissue-banked tumor sections and fresh human venous thrombus derived from cancer patients. Results: Plasma samples from cancer patients contained higher levels of nucleosomes (P=0.0009) and cfDNA (P=0.0008) compared to the non-cancer group. Western blot analysis revealed significantly lower DNase-1 protein levels (P=0.016) that paralleled lower nuclease activity (P=0.03) in plasma samples from cancer patients compared to non-cancer patients. Thrombus tissue from cancer patients and tumor tissue from liver and lung cancer also showed marked levels of NETs. However, increased levels of NETs in cancer patients did not correlate with TAT complex activation or prevalence of venous thrombosis in cancer patients. Conclusions: Further studies are warranted to determine the role of NETs as a procoagulant in human thrombosis.

AB - Background: A single center, prospective tissue-based study was conducted to investigate an association between neutrophil extracellular traps (NETs) and venous thromboembolic disease in patients with malignancy. Methods: Plasma was collected from 65 patients in which 27 were cancer patients and 38 were age-matched non-cancer patients. Plasma NETs, circulating free DNA (cfDNA), DNase-1, endonuclease-G, endonuclease activity and thrombin-antithrombin III (TAT) complex levels was quantified. Laboratory values were also compared. Additionally, NETs detection and quantification was performed with fluorescent immunohistochemistry (IHC) in tissue-banked tumor sections and fresh human venous thrombus derived from cancer patients. Results: Plasma samples from cancer patients contained higher levels of nucleosomes (P=0.0009) and cfDNA (P=0.0008) compared to the non-cancer group. Western blot analysis revealed significantly lower DNase-1 protein levels (P=0.016) that paralleled lower nuclease activity (P=0.03) in plasma samples from cancer patients compared to non-cancer patients. Thrombus tissue from cancer patients and tumor tissue from liver and lung cancer also showed marked levels of NETs. However, increased levels of NETs in cancer patients did not correlate with TAT complex activation or prevalence of venous thrombosis in cancer patients. Conclusions: Further studies are warranted to determine the role of NETs as a procoagulant in human thrombosis.

KW - NETs

KW - Neutrophil extracellular traps

KW - Nuclease

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=85038613424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038613424&partnerID=8YFLogxK

U2 - 10.21037/cdt.2017.08.01

DO - 10.21037/cdt.2017.08.01

M3 - Article

AN - SCOPUS:85038613424

VL - 7

SP - S140-S149

JO - Cardiovascular Diagnosis and Therapy

JF - Cardiovascular Diagnosis and Therapy

SN - 2223-3652

ER -